Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters

SIMPLE SUMMARY: Chemoresistance of bladder cancer has become a major obstacle to clinical treatment, especially in first-line treatments involving gemcitabine (GCB). Epithelial-mesenchymal transition (EMT) is highly correlated with GCB resistance but less correlated with GCB metabolism and less repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying-Si, Ho, Jar-Yi, Yu, Cheng-Ping, Cho, Chun-Jung, Wu, Chia-Lun, Huang, Cheng-Shuo, Gao, Hong-Wei, Yu, Dah-Shyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122772/
https://www.ncbi.nlm.nih.gov/pubmed/33922395
http://dx.doi.org/10.3390/cancers13092032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122772/
https://www.ncbi.nlm.nih.gov/pubmed/33922395
http://dx.doi.org/10.3390/cancers13092032

Ejemplares similares